MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0065189
Medgenix Pharma India Private Limited
Medgenix Pharma India Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹16.49 Cr
▲ 31% YoY
Net profit · FY 2024
₹97.16 Lakh
Net margin 5.9%
EBITDA · FY 2024
₹1.58 Cr
EBITDA margin 9.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹1.26 Cr
Secured borrowings
Company age
11 yrs
Est. 2015
Employees · EPFO
21
Provident fund records
About Medgenix Pharma India Private Limited
Data last updated:
Medgenix Pharma India Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 02 June 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2015PTC099175. Its GSTIN is 36AAJCM8888Q1Z5 (Telangana).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Bhasker Uppala and Sudhakar Vaddi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹16.49 Cr, a growth of 31% compared to the previous year. For the same year it recorded a net profit of ₹97.16 Lakh (net margin 5.9%) and EBITDA of ₹1.58 Cr (EBITDA margin 9.6%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 10% over five years.
The company has about 21 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.26 Cr on record.
Medgenix Pharma India Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0065189). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24100TG2015PTC099175
Registration Number 099175
Incorporation Date 02 June 2015
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-02-0065189
Recognitions & Rankings of Medgenix Pharma India
Contact details
Medgenix Pharma India Private Limited's registered office is in Hyderabad, Telangana. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No 9 /GF/Ff/Sf Sy No 13 14 15A 16 17A, Sanjeevaiah Co Op Housing Society Tadbund, Hyderabad, Telangana, India – 500009
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Medgenix Pharma India Private Limited, buy the company report.
Comprehensive company report
Medgenix Pharma India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Medgenix Pharma India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medgenix Pharma India Private Limited, buy the company report.
Financials of Medgenix Pharma India Private Limited
FY 2025 filings availableMedgenix Pharma India Private Limited reported revenue of ₹16.49 Cr (up 31% YoY) for FY 2024.
Revenue · FY 2024
₹16.49 Cr ▲ 31%
Net profit · FY 2024
₹97.16 Lakh margin 5.9%
EBITDA · FY 2024
₹1.58 Cr margin 9.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 31%
3 years · compounded
▲ 13%
5 years · compounded
▲ 10%
EBITDA CAGR growth
1 year
▲ 126%
3 years · compounded
▲ 32%
5 years · compounded
▲ 14%
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 31% growth in the latest year. EBITDA rose 126% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹16.49 Cr | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.58 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹97.16 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.6% | ||||
| Net Profit Margin | 5.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Medgenix Pharma India Private Limited, buy the company report.
Board of directors of Medgenix Pharma India Private Limited
Medgenix Pharma India has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhasker Uppala | Director | 25 Apr 2017 | 9 Years 6 Months | Current |
| Sudhakar Vaddi | Director | 25 Apr 2017 | 9 Years 6 Months | Current |
| Suresh Boyidi | Director | 25 Apr 2017 | 9 Years 6 Months | Current |
Peer comparison
Medgenix Pharma India Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aaron Healthcare & Export Private Limited | ₹16.59 Cr (FY 2025) | -22.0% | Patna, Bihar, India | |||
| Medgenix Pharma India Private Limitedthis company | ₹16.49 Cr (FY 2024) | ₹97.16 Lakh | 5.9% | 31.0% | Hyderabad, Telangana, India | |
| Azkka Pharmaceuticals Private Limited | ₹16.46 Cr (FY 2025) | 16.0% | Ahmedabad, Gujarat, India | |||
| Adaarsh Pharmacon Industries Private Limited | ₹16.37 Cr (FY 2024) | 449.0% | Gulbarga, Karnataka, India | |||
| Nutra Life Healthcare Private Limited | ₹16.34 Cr (FY 2025) | 5.0% | Roorkee, Uttarakhand, India |
To see the full peer comparison of Medgenix Pharma India Private Limited, buy the company report.
Auditor
Medgenix Pharma India Private Limited is audited by THEJONATH AND ASSOCIATES for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| THEJONATH AND ASSOCIATES | FY 2024 | 017275S |
Shareholding
The shareholding of Medgenix Pharma India Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Medgenix Pharma India Private Limited, buy the company report.
Charges & borrowings
Open charges
₹1.26 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Jun 2024 | 100965032 | Hdfc Bank Limited | ₹21.32 Lakh | Open | |
| 06 Mar 2024 | 100884842 | Hdfc Bank Limited | ₹22 Lakh | Open | |
| 15 Nov 2023 | 100860133 | Hdfc Bank Limited | ₹13.57 Lakh | Open | |
| 04 Feb 2023 | 100696783 | Hdfc Bank Limited | ₹13.6 Lakh | Open | |
| 02 Aug 2022 | 100645847 | Hdfc Bank Limited | ₹27.45 Lakh | Open |
Total charge records: 6 View all charges
Legal cases
No court or tribunal cases involving Medgenix Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Medgenix Pharma India Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 2 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (1 of 1)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| V2 Pharmacueticals |
To see the full MSME payment records of Medgenix Pharma India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
GST
Medgenix Pharma India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAJCM8888Q1Z5 | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Medgenix Pharma India Private Limited, buy the company report.
Recent activity
Medgenix Pharma India Private Limited has 6 board changes on record since 2017: 3 appointments and 3 cessations. The latest: Neeta Raithatha ceased to be Additional Director on 18 Feb 2019.
AGM
Medgenix Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Medgenix Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 21.32 Lakh with Charge ID 100965032 was registered on 29 Jun 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 22.00 Lakh with Charge ID 100884842 was registered on 06 Mar 2024.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 13.57 Lakh with Charge ID 100860133 was registered on 15 Nov 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 13.60 Lakh with Charge ID 100696783 was registered on 04 Feb 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 27.45 Lakh with Charge ID 100645847 was registered on 02 Aug 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 27.99 Lakh with Charge ID 100873972 was registered on 29 Jun 2022.
Ceased
Neeta Raithatha ceased to be Additional Director.
Ceased
Savithri Kalluri ceased to be Director.
Ceased
Venkateswara Rao Rangineni ceased to be Director.
Appointed
Bhasker Uppala was appointed as Director.
3 earlier events are in the company report.
Frequently asked questions
Medgenix Pharma India is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 02 June 2015 (11+ years old) and is registered under CIN U24100TG2015PTC099175.
Medgenix Pharma India has 3 current directors:
- Bhasker Uppala - Director
- Sudhakar Vaddi - Director
- Suresh Boyidi - Director
The latest financial statements of Medgenix Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2016 are in the company report.
The GSTIN of Medgenix Pharma India is 36AAJCM8888Q1Z5, registered in Telangana.
The CIN (Corporate Identification Number) of Medgenix Pharma India is U24100TG2015PTC099175. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medgenix Pharma India was incorporated on 02 June 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Medgenix Pharma India by revenue are Aaron Healthcare & Export Private Limited, Azkka Pharmaceuticals Private Limited, Adaarsh Pharmacon Industries Private Limited, Nutra Life Healthcare Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Neeta Raithatha ceased to be Additional Director on 18 Feb 2019. Savithri Kalluri ceased to be Director on 08 May 2017. Venkateswara Rao Rangineni ceased to be Director on 08 May 2017. Medgenix Pharma India has 6 board changes on record in total.
Yes, Medgenix Pharma India is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0065189).
Medgenix Pharma India has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 2 overdue payments to 1 micro and small supplier. The latest return was filed on 08 Jun 2019.
The registered office of Medgenix Pharma India is at Plot No 9 GFFfSf Sy No 13 14 15A 16 17A, Sanjeevaiah Co Op Housing Society Tadbund, Hyderabad, Telangana, India – 500009.
Medgenix Pharma India operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages